English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 851625      Online Users : 940
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10236


    Title: Human placenta-derived multipotent cells (PDMCs) protect against Klebsiella pneumoniae-induced pneunomia by enhancing polymorphonuclear granulocytes (PMN) functions
    Authors: Wang, LT;Chao, YY;Lee, W;Huang, LY;Liu, KJ;Siu, LK;Yen, BL
    Contributors: Institute of Cellular and Systems Medicine;Division of Infectious Diseases;National Institute of Cancer Research
    Abstract: Human mesenchymal stem cells (MSCs) are multilineage somatic progenitors with strong immunomodulatory properties which have been well-demonstrated for T lymphocytes and dendritic cells/macrophages. However, interactions with neutrophils (polymorphonuclear granulocytes or PMNs)—the most abundant population of human leukocytes—are less well understood. Therefore, we investigated the interactions of human placenta-derived multipotent cells (PDMCs), a population of fetal-stage MSCs, with PMNs through in vitro studies and a mouse model of Klebsiella pneumoniae (KP)-induced pneumonia. KP is a highly virulent gram-negative bacterium and a leading cause of community- and hospital-acquired infections, especially pneumonia. We found that after co-culture with PDMCs, PMN expression of CD11b—a marker of activation—as well as phagocytosis of FITC- labeled KP was significantly increased. Moreover, PMN oxidative metabolism was significantly increased as well, which manifested as increased anti-bacterial activity and improved killing of KP. To ascertain the therapeutic efficacy of PDMCs on bacterial infections, we infected wild type mice with KP by intratracheal inoculation with subsequent intravenous administration of PDMCs. Surprisingly, while injection of PDMCs reduced the influx of PMNs in KP-infected lung tissue, respiratory burst activity was simultaneously enhanced. PDMC treatment also decreased bacterial counts both locally in lung tissue and systemically in the bloodstream. Most importantly, administration of PDMCs significantly increased survival rates in this mouse model of KP pneumonia. Taken together, we found that PDMCs enhance PMN functions in vitro and in vivo towards KP without increasing overall lung inflammatory damage. Our data strongly implicate a possible therapeutic role for PDMCs towards gram-negative bacterial infections.
    Date: 2016-08
    Relation: European Journal of Immunology. 2016 Aug;46(Suppl. 1):1242.
    Link to: http://dx.doi.org/10.1002/eji.201670200
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0014-2980&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000391563600009
    Appears in Collections:[顏伶汝] 會議論文/會議摘要
    [蕭樑基] 會議論文/會議摘要
    [劉柯俊] 會議論文/會議摘要

    Files in This Item:

    File Description SizeFormat
    ISI000391563600009.pdf130KbAdobe PDF473View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback